Clinical Trial Update: CD34+ Stem Cell Infusion to Augment Graft Function [Phase 2]

View source ↗

Summary

Phase 2 trial investigating CD34+ stem cell infusion to augment graft function; the study was terminated with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Marrow Failure
• Immunodeficiency Disease
• Waning Donor Chimerism
• Waning Immune Function

Drugs mentioned

• CD34+ stem cell infusion

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Waning Donor Chimerism, Waning Immune Function | Phase 2 | Status: TERMINATED | Results posted: 2019-10-22